Jupiter Research Capital (Asia) Ltd’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Jupiter Research Capital (Asia) Ltd's APGE Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 10,918 shares — an estimated $1.45M sold.
Jupiter Research Capital (Asia) Ltd first reported a position in APGE in Q4 2025 and held it in 2 quarters. The position peaked at $1.45M in Q2 2026. 3 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 10,918 Apogee Therapeutics shares in Q3 2026, an estimated $1.45M.
- Jupiter Research Capital (Asia) Ltd first reported a position in Apogee Therapeutics in Q4 2025 and held it in 2 quarters.
- Jupiter Research Capital (Asia) Ltd's Apogee Therapeutics position peaked at $1.45M in Q2 2026.
- 3 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.